Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 19.80
-0.50 (-2.46%)
Apr 24, 2026, 3:10 PM CET
Navamedic ASA Earnings Call Transcripts
Fiscal Year 2025
-
The acquisition of dne Pharma's business for up to NOK 225 million expands product ownership in addiction treatment, with significant synergies and an expected EBITDA boost to NOK 25 million. Integration is straightforward, with most cost savings realized quickly.